©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: David Pidduck
MediPharm Labs Reports Q1 2025 Financial Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, reported financial results for the three months ended March 31, 2025 ("Q1 2025").
The company...
MediPharm Labs Reports Full Year and Q4 2024 Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, announced its financial results for the full year and three months ended December 31, 2024.
MediPharm...
MediPharm Labs to Sell Hope Facility to Rubicon Organics for $4.5M
TORONTO - MediPharm Labs Corp. and Rubicon Organics Inc. have reached an agreement under which Rubicon will purchase MediPharm's facility in Hope, B.C., for $4.5 million in cash....
MediPharm Labs Terminates Proposed Sale of Facility to Kensana Health
TORONTO - MediPharm Labs Corp. terminated the previously announced sale of its facility in Napanee, Ontario, to Kensana Health Inc., which was to be completed...
Kensana Health Buys MediPharm’s Napanee Facility for $5.5M
TORONTO - MediPharm Labs Corp. and Kensana Health Inc. have entered into a share purchase agreement for the purchase and sale of MediPharm's facility in...
MediPharm Labs Reports Third Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30, 2024.
Key...
MediPharm Labs Announces $2.1M Debt Repayment
TORONTO - MediPharm Labs Corp., a specialized, research-driven pharmaceutical company focused on cannabis-based health products, has paid off the entire remaining convertible debt amount of $2.1...
MediPharm Labs Reports Second Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids reported its financial results for the three and six months ended June 30,...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the...
MediPharm Labs Reports First Quarter Results
TORONTO - MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.
Select Highlights
Revenue increased...